Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,602,133

« Back to Dashboard

Patent 5,602,133 protects PRELAY and REZULIN and is included in two NDAs.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: 5,602,133

Title: Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
Abstract:Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.
Inventor(s): Antonucci; Tammy (Meguon, WI), Lockwood; Dean (Ann Arbor, MI), Norris; Rebecca (Kewadin, MI)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/469,398
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Compound;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sankyo
PRELAY
troglitazone
TABLET;ORAL020719Jan 29, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Sankyo
PRELAY
troglitazone
TABLET;ORAL020719Aug 4, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720Jan 29, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720Aug 4, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expiration for: 5,602,133

Expiration due to failure to pay maintenance fee
Patent Number:5,602,133 Tradename:
PRELAY
Expiration Date:February 11, 2009
Patent Number:5,602,133 Tradename:
REZULIN
Expiration Date:February 11, 2009

International Patent Family for Patent: 5,602,133

Country Document Number Publication Date
South Africa9804084Nov 20, 1998
South Africa9804798Dec 29, 1998
World Intellectual Property Organization (WIPO)9507694Mar 23, 1995
World Intellectual Property Organization (WIPO)9507697Mar 23, 1995
World Intellectual Property Organization (WIPO)9851305Nov 19, 1998
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc